CARMAT SA’s €60 Million Reserved Offering

Jones Day advised CARMAT SA,

Jones Day advised CARMAT SA, a designer and developer of the world’s most advanced heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, in connection with its €60 million (US$66.3 million) share capital increase, reserved for investors, specialists of the healthcare and life sciences industry, or strategic partners of CARMAT.

Jones Day team was led by Charles Gavoty (Picture).

Involved fees earner: Charles Gavoty – Jones Day;

Law Firms: Jones Day;

Clients: Carmat SA;